Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

Paxlovid is Australia's first-line COVID antiviral but Lagevrio also prevents severe disease in over-70s

By Benjamin Cowie, Director, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
Brett Sutton, Adjunct Clinical Professor, Monash University
Christina Van Heer, PhD candidate at The School of Medicine, Dentistry and Health Sciences, The University of Melbourne
Suman Majumdar, Deputy Program Director, Health Security and Pandemic Preparedness, Burnet Institute
Share this article
Analysis of Victoria’s winter COVID wave found Paxlovid and Lagevrio reduced the risk of hospitalisation and death. The results were better for Paxlovid, but not everyone can take it.The Conversation


Read complete article

© The Conversation -
Subscribe to Tolerance.ca


Follow us on ...
Facebook Twitter